Spotting Serious Diagnoses among Common Neurological Conditions
This webinar was featured live July 19 and 20, 2022. Please register to view the recording.
RegisterMigraines and bipolar disorder are treated with some of the same multi-use drugs. So are restless leg syndrome and Parkinson’s disease. Accurately assessing mortality risk in such cases means knowing more than what drug was prescribed—it also means knowing why. In this webinar, you’ll learn how to use the enhanced information in Prescription Data, such as prescriber specialty or fill quantity, as well as Medical Data, to instantly differentiate between common, benign neurological conditions and a range of more serious concerns including mental health and even cardiac issues. Don’t miss those red flags.
Topics covered
- Summaries of Migraine, restless leg syndrome (RLS), Parkinson’s disease, and their available treatment options
- Multi-use drugs prescribed for common neurological diagnoses (such as migraines and RLS) that are also prescribed for red-flag conditions such as bipolar disorder, Parkinson’s disease, epilepsy, and substance use disorder
- Using Prescription Data, Medical Data, and Irix® to instantly clarify which condition is indicated by the available data
- Using updated Prescription Data with Medical Data to stratify risks for patients with serious conditions like diabetes or heart failure
Who should attend
Medical directors, underwriters, and other clinical professionals working in the insurance industry will benefit from a review of significant new drug therapies—and a refresher on the insurtech that helps carriers see both risks and opportunities, to quickly make the best-informed decisions.
Presenters
Hayley Vrchota, PharmD, CTTS
Clinical Consultant
Kevin Doran
Product Director, Prescription Data
Jenna Fariss, ASA, MAAA
Actuary and Product Director, Medical Data
